![Who Is at Risk for HIV Infection and Which Populations Are Most Affected? | National Institute on Drug Abuse (NIDA) Who Is at Risk for HIV Infection and Which Populations Are Most Affected? | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/2020-06/rrhiv_fig04b.jpg)
Who Is at Risk for HIV Infection and Which Populations Are Most Affected? | National Institute on Drug Abuse (NIDA)
![Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand - eClinicalMedicine Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand - eClinicalMedicine](https://www.thelancet.com/cms/asset/86be3b62-16f8-4cb5-9973-2023d94e2747/gr1.jpg)
Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand - eClinicalMedicine
![Who Is at Risk for HIV Infection and Which Populations Are Most Affected? | National Institute on Drug Abuse (NIDA) Who Is at Risk for HIV Infection and Which Populations Are Most Affected? | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/styles/content_image_large/public/2020-06/rrhiv_fig03.jpg?itok=Oqcn3hYd)
Who Is at Risk for HIV Infection and Which Populations Are Most Affected? | National Institute on Drug Abuse (NIDA)
![Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study - The Lancet Public Health Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study - The Lancet Public Health](https://www.thelancet.com/cms/asset/b8660fa4-1037-4521-ba06-cf3577fc326a/gr1.gif)